GRAY MARY ANN 1261974 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-15 | 2023-03-31 | 2023-03-31 | 4 | Gray Mary Ann | DIRECTOR | acq | 5503.0 | 30.9 | 1.15 | 0.0 | Direct | Common Stock | BIOATLA, INC. | code A | 17810.0 | 47.67 (BCAB) |
2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Gray Mary Ann | DIRECTOR | acq | 4916.0 | 21.63 | 1.03 | 0.0 | Direct | Common Stock | BIOATLA, INC. | code A | 22726.0 | 47.67 (BCAB) |
2023-10-03 | 2023-09-30 | 2023-09-30 | 4 | Gray Mary Ann | DIRECTOR | acq | 8676.0 | 27.63 | 1.81 | 0.0 | Direct | Common Stock | BIOATLA, INC. | code A | 31402.0 | 47.8 (BCAB) |
2024-01-03 | 2023-12-31 | 2023-12-31 | 4 | Gray Mary Ann | DIRECTOR | acq | 5995.0 | 16.03 | 1.25 | 0.0 | Direct | Common Stock | BIOATLA, INC. | code A | 37397.0 | 47.94 (BCAB) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-25 | 2023-05-24 | 2023-05-24 | 4 | Gray Mary Ann | DIRECTOR | acq | 12940.0 | 100.0 | 3.77 | 20.93 | Direct | Stock Option (Right To Buy) | RAPT THERAPEUTICS, INC. | code A | 12940.0 | 34.35 (RAPT) |
2023-06-08 | 2023-06-06 | 2023-06-06 | 4 | Gray Mary Ann | DIRECTOR | acq | 10000.0 | 100.0 | 3.38 | 48.79 | Direct | Stock Option (Right To Buy) | KEROS THERAPEUTICS, INC. | code A | 10000.0 | 29.58 (KROS) |
2023-06-13 | 2023-06-11 | 2023-06-11 | 4 | Gray Mary Ann | DIRECTOR | acq | 5100.0 | 100.0 | 7.62 | 0.0 | Direct | Restricted Stock Units | PALISADE BIO, INC. | code A | 5100.0 | 6.7 (PALI) |
2023-06-13 | 2023-06-11 | 2023-06-11 | 4 | Gray Mary Ann | DIRECTOR | acq | 12160.0 | 100.0 | 18.16 | 1.6 | Direct | Common Stock Options | PALISADE BIO, INC. | code A | 12160.0 | 6.7 (PALI) |
2023-06-15 | 2023-06-14 | 2023-06-14 | 4 | Gray Mary Ann | DIRECTOR | acq | 50000.0 | 100.0 | 10.49 | 3.55 | Direct | Stock Option (Right To Buy) | BIOATLA, INC. | code A | 50000.0 | 47.67 (BCAB) |
2023-11-24 | 2023-11-21 | 2023-11-21 | 4 | Gray Mary Ann | DIRECTOR | acq | 5820.0 | 100.0 | 6.31 | 0.0 | Direct | Restricted Stock Units | PALISADE BIO, INC. | code A | 5820.0 | 9.22 (PALI) |
2023-11-24 | 2023-11-21 | 2023-11-21 | 4 | Gray Mary Ann | DIRECTOR | acq | 6880.0 | 100.0 | 7.46 | 0.59 | Direct | Common Stock Options | PALISADE BIO, INC. | code A | 6880.0 | 9.22 (PALI) |
2024-02-14 | 2024-02-09 | 2024-02-09 | 4 | Gray Mary Ann | DIRECTOR | acq | 40000.0 | 100.0 | 3.14 | 1.57 | Direct | Stock Option (Right To Buy) | COMPASS THERAPEUTICS, INC. | code A | 40000.0 | 127.49 (CMPX) |
2024-04-01 | 2024-03-28 | 2024-03-28 | 4 | Gray Mary Ann | DIRECTOR | acq | 8574.0 | 100.0 | 2.49 | 8.98 | Direct | Stock Option (Right To Buy) | RAPT THERAPEUTICS, INC. | code A | 8574.0 | 34.4 (RAPT) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)